Tech Company Financing Transactions
Peptilogics Funding Round
Peptilogics, operating out of Pittsburgh, secured $5.5 million from BlueTree Ventures and private investors.
Transaction Overview
Company Name
Announced On
9/30/2017
Transaction Type
Venture Equity
Amount
$5,500,000
Round
Series A
Investors
Proceeds Purpose
The funding received will fuel the expansion of the company and its eCAP platform, particularly the continued development of its first clinical candidate in preparation for an IND submission next year.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2730 Sidney St. 300
Pittsburgh, PA 15203
USA
Pittsburgh, PA 15203
USA
Phone
Undisclosed
Website
Email Address
Overview
Peptilogics is an early-stage biotechnology company utilizing an innovative platform technology which enables us to rapidly and effectively develop novel peptide therapeutics, with a focus on antibiotics. Our pipeline includes a novel class of engineered Cationic Antimicrobial Peptides (eCAPs).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sanjay Kakkar
Chief Medical Officer
Todd Lorenz
Chief Scientific Officer
Jonathan Steckbeck
Browse more venture capital transactions:
Prev: 9/30/2017: Trellis Solutions venture capital transaction
Next: 9/30/2017: SkyCision venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are derived from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs